• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX
Click for more information
0.00% 6.0¢

AMPLIA THERAPEUTICS LIMITED

Market Cap $11.64M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company’s pipeline includes AMP945 and AMP886. AMP945 is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company’s second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX
Ann: Entitlement Offer - Offer Booklet 		04/05/24 3 1.0K
04/05/24 Last post  Dimitrios63 Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
ATX
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		02/05/24 5 1.1K
02/05/24 Last post  brrrattt Comments Created with Sketch.  5  Views Created with Sketch.  1.1K 
ATX
Unfair treatment to Non Aus shareholders 		24/04/24 2 770
24/04/24 Last post  markwhite Comments Created with Sketch.  2  Views Created with Sketch.  770 
ATX
Ann: Update on ACCENT Trial in Pancreatic Cancer 		23/04/24 44 11K
23/04/24 Last post  petesherl Comments Created with Sketch.  44  Views Created with Sketch.  11K 
ATX
Ann: Trading Halt 		22/04/24 21 6.4K
22/04/24 Last post  leveller Comments Created with Sketch.  21  Views Created with Sketch.  6.4K 
ATX
News: ATX Amplia Therapeutics Says Fully Underwritten 2 For 5 Entitlement Offer 		16/04/24 0 183
16/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  183 
ATX
Ann: Proposed issue of securities - ATX 		16/04/24 0 194
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 
ATX
Ann: Entitlement Offer Cleansing Statement 		16/04/24 0 196
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  196 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:29
 
Entitlement Offer - Offer Booklet
24 Apr 12:32
 
Proposed issue of securities - ATX
16 Apr 10:08
 
Entitlement Offer Cleansing Statement
16 Apr 10:08
 
Rights Issue Investor Slide Deck
16 Apr 10:08
 
Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27
16 Apr 10:07
 
View More arrow Created with Sketch.

Featured News

ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.

Latest Videos

Amplia Therapeutics mints $2.4m R&D tax benefit


20 Oct 2023 10:46 (AEDT)

(20min delay)
Last
6.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.64M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 25703 1
View Market Depth
Last trade - 10.36am 09/05/2024 (20 minute delay) ?
Last
6.2¢ 		  Change
0.000 ( 3.33 %)
Open High Low Volume
6.2¢ 6.2¢ 6.2¢ 86082
Last updated 11.10am 09/05/2024 ?
ATX (ASX) Chart

Top Stories

CBA profits fall 3% in March quarter but funding portfolio is flourishing

Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.

Featured News

PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.